Clinical Trial Update: A Phase 1 Study of the Safety and Tolerability of CTX-10726 [Phase 1]

View source ↗

Summary

Phase 1 study update on the safety and tolerability of CTX-10726, currently recruiting across gastroesophageal cancer, hepatocellular carcinoma, endometrial can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Gastroesophageal Cancer
• Hepatocellular Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• CTX-10726

Snippet

Sponsor: Compass Therapeutics | Conditions: Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC) | Phase 1 | Status: RECRUITING